Network Pharmacology Integrated with Transcriptomics Analysis Reveals Ermiao Wan Alleviates Atopic Dermatitis via Suppressing MAPK and Activating the EGFR/AKT Signaling

BACKGROUND: Ermiao Wan (EMW) is commonly used to treat atopic dermatitis (AD) in China. However, the pharmacological mechanisms underlying the action of EMW against AD remain unclear. PURPOSE: We aimed to determine the mechanisms underlying the effectiveness of EMW in the treatment of AD. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Ting, Liang, Xiao, Liu, Chang-Shun, Hu, Yan-Nan, Luo, Zhen-Ye, Tan, Xiao-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790806/
https://www.ncbi.nlm.nih.gov/pubmed/36578822
http://dx.doi.org/10.2147/DDDT.S384927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790806/
https://www.ncbi.nlm.nih.gov/pubmed/36578822
http://dx.doi.org/10.2147/DDDT.S384927

Ejemplares similares